Dr. Reddy's Laboratories kundali

Dr. Reddy's Laboratories (DRREDDY, Healthcare) was incorporated on 30 May 2003. This page shows its birth chart, its dasha periods since listing and how the share moved in each.

Dr. Reddy's Laboratories birth chart

Lagna Karka, lagna lord Chandra in the 11th house. Moon in Vrishabha, Krittika pada 3.

Dr. Reddy's: a Moon-strong chart that rewards patience and punishes haste

A company built to grow, tested by shocks

Dr. Reddy's Laboratories is a company whose chart shows strength in leadership, authority and earnings power. Chandra, the Moon, is exalted in the house of gains, and Mangal and Guru are both strong. Its history bears this out. The price record begins in November 1996 at ₹10.0 and stands at ₹1,380 today, a rise of 13,713%. Its highest close was ₹1,395 in August 2024.

This reading follows the company from its NSE listing day, 30 May 2003, to today, period by period. The incorporation date is not on public record, so the chart is cast for the listing day. The hour is not on record either, so the houses are indicative while the Moon and the dashas are firm.

The one idea the reading keeps returning to is that the same chart gives both rewards and shocks. The best stretch was the Moon–Jupiter period, March 2009 to July 2010, when the share rose 258% against 99% for the Nifty. The worst was Sun–Sun, April 2000 to July 2000, a fall of 26%. The USFDA warning letter of November 2015 came in a Moon period and was followed by a fall of 27%.

The chart did not call every move. In the Rahu years from April 2023 the share rose 33% to December 2025, behind a Nifty gain of 47%. Today the company reports revenue of ₹33,097 crore, down 3.5% on the year, and profit of ₹2,800 crore.

Strong leadership and gains, weak on earnings and oversight

The chart is cast for 10:00 IST on the listing day, but the hour is not on record, so the houses are indicative while the Moon and the dashas are firm.

First, the strength. Chandra, the Moon, is exalted in the house of gains, and Guru, the planet of expansion, is exalted in the first house of the company's own identity. Mangal, the planet of energy and drive, is also exalted and rules both work and effort in this chart. Together they describe a company that builds, expands and wins. The record shows it: the share rose 258% in the Moon–Jupiter period from March 2009 to July 2010, against 99% for the Nifty, and 96% in Mars–Mercury from October 2019 to October 2020.

Second, the balance sheet holds steady. The strain houses, which speak of debt and disputes, score well today. Debt is 0.15 times equity, operating profit covers interest 8.8 times, and operating cash is 1.35 times reported profit. The company has not been pushed into financial trouble, even in hard years.

Third, the weak spot is the house of gains in recent results. Surya, the Sun, which rules the second house of income, sits in an enemy sign and is among the chart's weakest planets. The latest figures match: revenue is down 1.5% and profit down 31.3% on the year to 30 September 2026, against 22.5% and 15.3% for the median Healthcare company. Return on equity is 7.2% against 12.2% for peers.

Fourth, Shani, the planet of discipline and delay, sits in the twelfth house of losses and outside matters. It is weak here and ties to inspections, penalties and leadership strain. The company filed 11 management change notices and 6 legal or tax filings in the last year. The chart does not predict every move: in Mars–Rahu from September 2016 to September 2017 the share fell 27% while the Nifty rose 10%, and the chart gives no clean reason for it.

Surya's six years: a rise of 81% with deep dips

The first six years of this record, April 2000 to April 2006, belong to Surya, the Sun, the planet of authority. The share ended the stretch 81% higher, but it got there through three falls of 30% or more and a few sharp swings.

The reason is plain. Surya rules the house of income here and sits in an enemy sign in the house of gains, beside Chandra and Rahu. That gives real earning power, but without steadiness. Gains arrived in bursts and were taken back quickly.

For an owner, this era shows a company that grew fast and unevenly. The big years came in the sub-periods of Shani, Shukra and Rahu, while Budh and Guru brought the losses. The nine sub-periods below show how each one played out.

A 26% fall to open the record

The Sun period opened badly. From April to July 2000 the share fell 26%, and at its worst point it was down 32%. No company event is recorded in these months, so the fall was the market's own verdict. This was the worst stretch in the share's entire history.

Surya is its own sub-period lord here, and it rules the house of wealth while sitting in an enemy sign. Authority and income were both in play, but the planet had little comfort in its placement, so the chart reads this opening as a testing one. The chart and the share agreed.

For an owner, the lesson is about starting points. A strong company can still open a cycle with a quick drop, and that drop was not a verdict on the business, since the period that followed recovered. The first quarter of the record shows how sentiment can turn hard in a few weeks.

Chandra brings a gentle 14% recovery

From July 2000 to January 2001 the share rose 14%. No major filing falls inside these months, so the climb was a quiet repair of the earlier damage rather than a story of new orders.

Chandra, the Moon, is the strongest planet in this chart. It is exalted and rules the first house, the house of the company itself. Its sub-period carries a steadier mood after Surya's rough start. The gain was modest because Chandra sits combust, burnt by the nearness of the Sun, which dims its light.

What this tells you is that the company's own strength, once it is left alone, rebuilds value without drama. The recovery was ordinary and unspectacular, and the chart reading fits that. It also shows the pattern that runs through this record: after a hard stretch, a Chandra phase restores some of the loss.

A New York listing amid a volatile spring

From January to June 2001 the share rose 10%, yet it fell 31% at its worst point along the way. The sharpest day came on 6 April 2001, a drop of 10%. On 11 April 2001 the company listed its ADRs on the New York Stock Exchange, a milestone for a business with global ambitions.

Mangal, Mars, is the chart's yogakaraka, the planet that rules both work and creative effort. It sits exalted in the house of partnerships. That fits an overseas listing, which is a partnership with new markets. Mars also brings heat, which explains the violent swings inside a positive result.

The tale for an owner is that a good decision does not guarantee a calm ride. The listing widened the company's reach, but the share first sold off hard. The chart read the milestone correctly, though not the day-to-day nerves around it.

Rahu's year adds 36%, with one brutal day

From June 2001 to May 2002 the share rose 36%. This was one of the stronger stretches of the era. The swings list also records a one-day move of 49.98% downward on 15 October 2001, a figure that looks like a data break after the ADR listing, so treat it as noise rather than a business event.

Rahu, the planet of sudden and foreign influence, sits in the house of gains in this chart. Its sub-period favours expansion that comes from outside the usual path, which matches the fresh overseas shareholder base created by the New York listing earlier in 2001.

For an owner, this shows that the company's international reach was producing results within a year. The share ended the period well ahead, so the chart and the share agreed. It also shows how Rahu's gains can come with confusing headlines.

Guru's year turns choppy and slightly negative

From May 2002 to February 2003 the share slipped 10%, with a 32% fall at its worst point. No company event is recorded in this window, so the weakness came from the share's own mood rather than a single piece of news.

Guru, Jupiter, is the planet of expansion and sits exalted in the first house. Yet it rules the sixth house of debts and disputes, and that side showed here. A planet this strong still gave a poor result, so this is a case where the share went against the chart's broad promise.

What this tells an owner is that the company's strength did not protect it from a mid-cycle slump. The drop was deep but it ended in a smaller net loss, and the next sub-period brought a clear recovery. The pattern is of a company that dips hard and then repairs.

Shani's year: NSE listing and a 56% rise

From February 2003 to January 2004 the share rose 56%. On 30 May 2003 the company listed on the NSE, which is the date this chart is cast for. Domestic investors gained direct access to the share in this window.

Shani, Saturn, is the planet of discipline and slow, earned results. It rules the seventh and eighth houses and sits in the twelfth, which forms a Viparita raja yoga, a pattern where gains come out of difficulty. The record shows the company had just come through the 2002 slump, and Shani rewarded that patience.

For an owner, this was a clean good stretch, and the share agreed with the chart. It also marks the point where the company became part of the main Indian market, a step that stayed useful in every later cycle.

Budh's year: the era's deepest slide

From January to December 2004 the share fell 40%, and at its worst point it was down 53%. On 1 March 2004 it dropped 18% in a single day. No filing in the record explains the day, so the cause is not known from these facts.

Budh, Mercury, rules the third house of effort and communication and the twelfth house of losses. It sits in the house of work. That mix of heavy effort with leakage fits a year in which business activity continued but value drained away. The chart reads this period as a hard one, and the share confirmed it.

For an owner, the point is how severe such a fall can be even when the business is not collapsing. The share later more than recovered, so this was a deep trough rather than a lasting break. It remains the second worst stretch of the era.

Ketu's short pause: a mild 11% fall

From December 2004 to April 2005 the share fell 11%. This was a short sub-period of only about four months, and no event is recorded inside it. It reads as a pause after the heavy fall of 2004.

Ketu, the planet of detachment, sits in the fifth house of strategy and judgement. Ketu does not give gains and does not chase them. Its sub-periods tend to cool enthusiasm, and the share's mild slip is what that looks like in practice.

For an owner, this was a quiet bottoming rather than a fresh crisis. The loss was small compared with the year before, and the next sub-period brought the biggest gain of the whole era. Short Ketu windows are best read as a reset, not as a warning.

Shukra closes the Sun era with a 95% surge

From April 2005 to April 2006 the share rose 95%, the best result in the whole Sun period. There was no fall of note and no company event is recorded, so this was a steady market re-rating of the business.

Shukra, Venus, rules the fourth and eleventh houses, the houses of assets and gains, and sits in the house of work. Both its houses speak directly to what a company earns and holds. This is the clearest case in the era of the chart and the share moving together.

For an owner, the message is that the company's best phases come when earnings and assets are both supported. After a 40% fall in 2004 and an 11% slip into early 2005, this surge repaid the pain. It set the stage for the long Chandra decade that followed.

Chandra's decade: a slow start, a great climb, one FDA blow

The Moon major period, from April 2006 to April 2016, was the best decade in this company's history. The share rose 349% over these ten years. It began with a flat year, took a hard fall in the global crisis, then climbed steadily from 2009.

The reason is simple. Chandra, the Moon, rules the first house of the company's own standing and sits exalted in the house of gains. Its decade therefore rewarded the business with growth that kept compounding. The weak spots came where Chandra met Mars, Rahu and Surya, the planets that pressed this chart.

For an investor the lesson is plain. This company grows well when its core strength is working, and it stumbles when outside shocks arrive, whether a market crash or a regulator. Nine stretches follow, each read in turn.

A flat year with a violent swing in May

From April 2006 to February 2007 the share ended where it began, at 0%, though it fell 31% at its worst point inside the period. The sharpest day came on 2 May 2006, when it jumped 17%. The year as a whole closed 66.5% higher for 2006, so the early weakness was recovered.

The reason is that Chandra was speaking to itself. The planet of the mind and of public mood rules the first house here, so the share swung with sentiment more than with any single business event. No filing in the record explains the moves.

What it tells you: when this company is in its own period, the share can be restless without the business changing. Do not read a sharp one-day jump or a deep dip in this chart as a verdict on the company. It took the rest of the decade for the real direction to show.

Mars brought a mild slide and no clear gain

From February 2007 to September 2007 the share fell 11%. No major company event is dated inside these months. The full year 2007 ended 9.2% lower, so the weakness was not rescued later in the calendar year.

Mangal, Mars, is the planet of drive and conflict, and in this chart it rules the fifth and tenth houses, those of strategy and work. It is exalted and strong, so the business itself held. But Mars sits in the house of partnerships and trade, and a Moon–Mars window pairs a mood planet with a heated one. The result was restlessness, not growth.

What it tells you: a strong planet does not always lift the share in every window. Here the chart read the business correctly but the share went the other way for a few months. This was a pause before the larger trouble that followed, not damage to the company's core.

The 2008 crash and a merger approved at the bottom

From September 2007 to March 2009 the share fell 36%, with a drop of 49% at its worst point. This was the hardest stretch of the decade. On 23 October 2008 the board approved a scheme of amalgamation in the middle of the fall. The year 2008 closed 35.6% lower, though the Nifty lost 51.8%, so the company held up better than the market.

Rahu is the planet of sudden shocks and foreign influences, and it sits in the house of gains with Chandra and Surya. Its periods bring volatility to income and sentiment, and the global financial crisis fits that pattern exactly.

What it tells you: in a world-wide panic this company fell, but less than the benchmark. A merger decision taken in the worst months shows a management willing to restructure while others waited. The chart marks Rahu windows as the ones to watch for shocks from outside.

The great run: 258% in sixteen months

From March 2009 to July 2010 the share rose 258%, against 99% for the Nifty. It was the best stretch in the company's history. The sharpest day came on 25 September 2009, a gain of 11%. On 17 May 2010 a court-ordered amalgamation process moved forward. Calendar 2009 closed 146.6% higher and 2010 another 46.2%.

Guru, Jupiter, the planet of expansion, sits exalted in the first house here and rules the sixth and ninth houses, those of competition and fortune. Together with Chandra's own strength, it gave this window both luck and the energy to win against rivals.

What it tells you: the company does best when Guru's energy is active and the market is recovering. It beat the index by a wide margin, so this was company strength and not just a rising market. This is the pattern to remember when judging any later Guru window.

Saturn slowed the pace, the share barely rose

From July 2010 to February 2012 the share rose 12%, while the Nifty finished flat at about 0%. Calendar 2011 closed 4.4% lower, but the Nifty lost 24.6% that year, so the company protected its holders well in a falling market.

Shani, Saturn, the planet of discipline and delay, rules the seventh and eighth houses and sits in the twelfth, the house of losses. This chart treats such a placement as one that turns crisis into gain over time. It brings slower, steadier progress after a sprint and makes the company hold its ground.

What it tells you: after the great run, growth cooled, but the company did not give back its gains. It kept pace in a weak market. A cautious period like this shows the business resisting downturns well, even when it does not race ahead.

Budh's window: steady gains and a clear lead over the market

From February 2012 to July 2013 the share rose 47%, against 12% for the Nifty. Calendar 2012 closed 17% higher and 2013 closed 39.4% higher, in each case ahead of the benchmark. No major regulatory event is recorded in these months.

Budh, Mercury, the planet of commerce and analysis, sits in the tenth house of work, beside Shukra. It rules the third and twelfth houses, those of effort and overseas links. That fits a company building its exports and carrying out routine business well.

What it tells you: a quiet, well-run stretch with no dramatic news can still beat the market by a wide gap. For this company, the best returns often come from steady execution and not from announcements. The lead over the Nifty here was nearly four times the index's gain.

Ketu's short pause: modest gain, little to report

From July 2013 to February 2014 the share rose 13%, against 1% for the Nifty. It was a short window with no filing, merger or regulatory event dated inside it. The company simply carried on.

Ketu is the shadow planet of detachment and sits in the fifth house of strategy and judgement. It has no house to rule and gives results through its dispositor, Mangal, the strong planet of this chart. So the window ran quietly, powered by Mars's strength and not by anything new.

What it tells you: a Ketu stretch is a breather. The share still beat the market, which shows the business had momentum left from the Mercury window. The lesson is that this company does not need constant news to keep moving, but also does not make big leaps when no new driver is present.

Shukra's long climb, then a pause at the top

From February 2014 to October 2015 the share rose 61%, against 34% for the Nifty. This was the longest sub-period of the decade, lasting nearly twenty months. Calendar 2014 closed 29% higher, almost level with the Nifty's 31.4%, and 2015 closed 3.7% lower against a 4.1% fall for the index.

Shukra, Venus, the planet of comfort and income, rules the fourth and eleventh houses, those of assets and gains, and sits in the tenth house of work. That is a strong setting for earnings, and the first half of the window rewarded it. The second half cooled as the cycle neared its end.

What it tells you: the gains came early and the share then drifted sideways. In 2014 the company only matched the market, so the real outperformance came in the first months. Holders were paid for patience, but not evenly through the window.

Surya's period ends the decade with an FDA warning

From October 2015 to April 2016 the share fell 27%, against 3% for the Nifty, with a drop of 37% at its worst point. On 6 November 2015 the USFDA issued a warning letter covering three plants in Andhra Pradesh and Telangana. This was a clear business shock, and the share fell far more than the market.

Surya, the Sun, the planet of authority, is weak in this chart and sits in an enemy sign in the house of gains. It rules the second house of income. Its period brings pressure from officials and regulators, and the FDA letter fits exactly.

What it tells you: manufacturing compliance is this company's most exposed point. A single regulator's letter cut deeper than any market move in the decade. When you assess this company in any era, plant inspections deserve as much attention as results.

Mars years: one big surge amid long stretches of lag

The Mars major period ran from April 2016 to April 2023 and lifted the share 64% in total. Most of that came in a single year, October 2019 to October 2020. Outside it, the share often trailed the Nifty.

Mangal, the planet of drive and action, is the strongest planet in this chart and rules both the house of work and the house of the self. That is why the business kept building through these years, with plants, mergers and launches. The share rewarded only some of that effort. Each sub-period below shows where it paid and where it did not.

A flat summer, a buyback and one sharp fall

From April to September 2016 the share rose 4%, while the Nifty gained 13%. The company closed a buyback of its Rs 5 shares on 28 June 2016. On 27 July 2016 the share fell 10.2% in a single day, the sharpest move of the period.

Mangal here is both the major lord and the sub-lord, so the effect is doubled. Mangal rules the house of work and the house of intelligence and creation. This is a push to act, and the buyback was such an act. Action did not turn into steady gains in these months.

For an investor, the lesson is that this company can take a firm step and still see the market run ahead. In this stretch the share lagged the Nifty by a wide margin, and the chart did not shield it from a one-day shock.

A year when the share slid while the market rose

From September 2016 to September 2017 the share fell 27%, while the Nifty rose 10%. At its worst point inside the period the fall was 42%. The calendar year 2017 closed 20.5% lower against a 28.6% gain for the Nifty. This was one of the weakest years against the market in the whole record.

Rahu is the planet of sudden, disruptive swings, and it sits in the house of gains here, beside Surya and Chandra. It magnifies desire and then unsettles it. Rahu's sub-period often brings gains that arrive with a shock attached.

For an investor, this tells you the company's earlier strength was no protection when sentiment turned. The chart reads this as a year of pressure on the share more than on the business. The share went against the market, and the chart's strongest planets could not prevent it.

A modest recovery that still trailed the market

From September 2017 to September 2018 the share rose 14%, against 19% for the Nifty. It fell 26% at its worst point inside the period before recovering. The calendar year 2018 ended 9.3% higher against 3.2% for the Nifty.

Guru, the planet of expansion, is exalted in the first house and rules the house of rivals and the house of fortune. That mix brings growth that has to be earned against competition. It was a steady repair after the hard year before, not a breakout.

For an investor, the picture is of a business mending itself. Recovery was real, though still a little behind the market over the period, and the deep dip along the way shows the road was uneven. A strong planet gives support and does not remove difficulty.

Quiet progress and a merger filing

From September 2018 to October 2019 the share rose 3%, while the Nifty fell 2%. On 29 July 2019 the company recorded an amalgamation. The share held its ground in a weak market, which was a small win for the period.

Shani is the planet of discipline and delay. It rules the house of partnerships and the house of sudden change, and sits in the twelfth house of losses and outlay. Such a period asks for patience, slow work and restructuring, and it pays late. The merger work fits that picture.

For an investor, this stretch shows a company reorganising quietly while the market struggled. Results were not dramatic, but the share beat a falling index, and that kind of calm often comes just before a larger move.

The best year of the era: 96% gain

From October 2019 to October 2020 the share rose 96%, while the Nifty gained 5%. A further amalgamation was recorded on 25 November 2019. On 18 September 2020 the share jumped 10.5% in one day. The calendar year 2020 closed 82.2% higher against 14.9% for the Nifty.

Budh, the planet of trade and commerce, sits in the house of work and rules the house of effort and the house of outlay. In this chart it gives sharp business instincts. This is the one window in the Mars years where the chart and the share moved fully together.

For an investor, this shows what the company is capable of when its working house is activated: a pharma business that can outrun the market by a wide margin. It also shows that such years are rare, and the rest of the era was far quieter.

A pause after the surge, with the market pulling away

From October 2020 to March 2021 the share fell 13%, while the Nifty rose 25%. No company event is recorded inside the window. This was a hand-back of part of the previous year's gain, at a time when the whole market was running.

Ketu is the planet of detachment and release. It sits in the fifth house of creativity and judgement. Its periods tend to strip away excess and bring a pause, not new growth. The slide fits that nature.

For an investor, the lesson is that a very strong year can be followed by a cooling spell with no bad news behind it. The share went against the strength of the market here, and the chart read this as a rest, not as damage to the business.

A long, uncomfortable stretch of sliding and sharp dips

From March 2021 to May 2022 the share fell 12%, while the Nifty rose 10%. At its worst the fall reached 33%. On 27 July 2021 the share dropped 10.5% in a day. On 7 April 2022 the NCLT approved a scheme of amalgamation and arrangement. The calendar years 2021 and 2022 closed 5.3% and 13.1% lower.

Shukra, the planet of comfort and income, rules the house of gains and the house of assets. It sits in the house of work, yet is not strongly placed. The corporate steps went through, but the rewards did not reach the share price in this window.

For an investor, this was the weakest sustained stretch of the era against the market. The company completed its restructuring work, and the payoff came only later.

A short stretch that matched the market

From May 2022 to September 2022 the share rose 9%, the same as the Nifty's 9%. No company event is recorded in these months. After a long period of lagging, the share simply kept pace.

Surya, the Sun, rules the second house of wealth. It sits in the house of gains, in an enemy sign and weakly placed. Its period gives steady, modest returns and not any breakout. The chart's weakest planet gave an ordinary result, as expected.

For an investor, this shows the share finding its footing after the dip before it. It was a quiet window, with neither a setback nor a surge, and it marked the end of the long slide.

The era closed on a strong note, ahead of the market

From September 2022 to April 2023 the share rose 14%, while the Nifty slipped 1%. No company event is recorded inside these months. The Mars years ended with the share clearly ahead of the market.

Chandra, the Moon, rules the first house of the company itself and is exalted in the house of gains. It is among the chart's strongest planets. Its period lifts confidence and steadies the whole business.

For an investor, this closing window reflects what the chart's strongest planets can do when they take charge. After years of uneven results, the share ended the Mars era on firm footing, setting up the Rahu years that followed.

Rahu years: steady gains, slower than the market

The Rahu major period, from April 2023 to November 2026, lifted the share about 46% in total. For most of it the share trailed the Nifty. Rahu, the shadow planet of appetite and sudden turns, sits with the Sun and Moon in the house of gains in this chart. That is why the period brought real money but also noise, with news items and rumours around the company.

On the business side, the latest results show the cost. Revenue is down 1.5% and profit down 31.3% on the year to 30 September 2026, while the median Healthcare company grew far faster. The period ends with the company still earning more cash than profit, so the base is sound even as earnings slow. The two sub-periods below read quite differently.

Rahu–Rahu: a 33% climb that lagged the Nifty

From April 2023 to December 2025 the share rose 33%, against 47% for the Nifty. Calendar years were uneven: up 37.9% in 2023, up 20.5% in 2024, then down 7.9% in 2025. On 28 October 2024 the Rs 5 share was split into five of Rs 1. On 9 May 2025 G V Prasad was re-appointed Co-Chairman and Managing Director. On 10 November 2025 the exchange sought clarification on a news report about hackers duping the company.

The share went against the chart here. Rahu sits in the house of gains and should have carried the share past the market, yet it fell short. Rahu gives in bursts and then takes back, and the period's own lord does not rule any house, so it borrows its results from the Sun and Moon beside it.

For an investor, this stretch shows a company whose gains came from steady operations and leadership continuity rather than surprises. It also shows how a single news item can disturb the calm. Cash conversion stayed healthy, with operating cash at 1.35 times reported profit.

Rahu–Jupiter: a 10% rise while the Nifty slipped

From December 2025 to November 2026 the share rose 10%, while the Nifty fell 3.8%. The sharpest day came on 23 April 2026, a gain of 9.4%. The business news was mixed. In September 2026 the company signed an exclusive distribution deal with Takeda for Qdenga in India. In October it won DCGI approval for Zytorvi in a second cancer indication. In November it received marketing authorization for generic semaglutide in Brazil.

Against that, the top team kept changing. Director and auditor changes were filed in July, August and October 2026, and a small SEBI penalty of Rs 0.28 crore hit a US subsidiary, with no material impact according to the company.

The chart fits here. Guru, the planet of expansion, is exalted in the first house and also rules the sixth and ninth houses. It brought new approvals and partners, and the share beat the market. For an investor, the lesson is that growth in products is real, but profit is down 31.3% on the year and return on equity is only 7.2%. New launches have yet to reach the earnings.

Mangal and Rahu years brought the sharpest turns

Every named event in the record fell under a small set of grahas. The chart is cast for the NSE listing day, 30 May 2003, and the hour is not on record, so the houses are indicative while the Moon and the dashas are firm. Grouped by the planet that keeps recurring, the events show a clear pattern.

Mangal, the planet of drive and action, carries the most corporate restructuring. It rules the 5th and 10th houses here, the houses of strategy and of work, and it sits exalted in the 7th house of partnerships. The share's 28 June 2016 buyback closed in Mangal–Mangal–Budh. The amalgamations of 29 July 2019, 25 November 2019 and 7 April 2022 came in Mangal–Shani–Rahu, Mangal–Budh–Budh and Mangal–Shukra–Budh. Deals, mergers and capital actions suit a Mangal that works through partnerships. The same planet also gave the sharpest single-day falls of the Mars years, on 27 July 2016 and 27 July 2021. A strong Mangal builds, but it brings hard days too.

Chandra, the Moon, is the planet of the chart's self and sits exalted in the 11th house of gains, yet it is combust, burnt by the Sun's closeness. In Chandra's years two mergers came: the amalgamation scheme approved on 23 October 2008 in Chandra–Rahu–Shukra, and the High Court-sanctioned meeting of 17 May 2010 in Chandra–Guru–Rahu. The 6 November 2015 USFDA warning letter for three plants in Andhra Pradesh and Telangana came in Chandra–Surya–Chandra. So Chandra brought both gains and a regulatory blow. The warning letter fits the weak Surya, the planet of authority, in an enemy sign. Its period closed with the share down 27% while the Nifty fell 3%.

Surya, the Sun, held the early listings. The ADR listing on the New York Stock Exchange on 11 April 2001 fell in Surya–Mangal–Budh. The NSE listing on 30 May 2003 fell in Surya–Shani–Budh. Surya rules the 2nd house of wealth, so listings and fresh capital access belong to its years. The sharpest day in the record, a fall of 49.98% on 15 October 2001, also came in Surya–Rahu, and the record does not name its cause.

Rahu, the shadow planet, sits in the 11th house of gains with Surya and Chandra. It colours the most recent events. The stock split from Rs 5 to Re 1 on 28 October 2024 came in Rahu–Rahu–Budh. The reappointment of Mr G V Prasad as Co-Chairman and Managing Director on 9 May 2025 came in Rahu–Rahu–Shukra. On 10 November 2025, in Rahu–Rahu–Mangal, the exchange sought clarification on a news item about hackers duping the company. Rahu brings unusual, outside-in events: big corporate steps, leadership questions and public scrutiny.

The lesson for an owner is plain. Mangal brings deals and sharp swings, Chandra brings gains and regulatory friction, Surya brings listings, and Rahu brings the unexpected. The chart did not mark every date, and several events here, such as the 2016 buyback, did not move the share as the chart alone would suggest.

Jupiter and Venus lifted it; Mercury and Rahu pressed

Read across the periods and a pattern shows. Guru, the planet of expansion, is exalted in the first house of this chart and rules the 6th and 9th. Its sub-periods have mostly paid. Moon–Jupiter, from March 2009 to July 2010, gave the best run in the share's history: +258% against +99% for the Nifty. Mars–Jupiter was gentler, +14% against +19% for the Nifty, so Guru lifts the business but does not always beat the market.

Shukra, the planet of comforts and trade, rules the house of gains. Its windows have been generous. Sun–Venus gave +95% from April 2005 and Moon–Venus gave +61% against +34% for the Nifty. Mars–Venus is the exception, with a 12% fall from March 2021 while the Nifty rose 10%.

Budh, the planet of commerce, rules the 3rd and 12th houses, which carry effort and outflow. Its record is split. Moon–Mercury and Mars–Mercury gave +47% and +96%, yet Sun–Mercury cost 40% in 2004, with a one-day drop of 18%. Mercury rewards the company when its own plans are working and punishes it when they are not.

Rahu and Surya have pressed hardest. Moon–Rahu cost 36% and Mars–Rahu cost 27% while the Nifty rose 10%. Moon–Sun brought the USFDA warning letter of November 2015 and a 27% fall. Rahu's present major period has lagged the market too, with 33% against 47% in Rahu–Rahu.

The latest results lean the same way. Revenue is down 1.5% and profit down 31.3% on the year to September 2026, and return on equity of 7.2% trails peers at 12.2%. Cash is the bright side: operating cash is 1.35 times profit. The chart's pressure on earnings and oversight has shown up in the numbers.

The coming periods, with their dates and what each holds for the business, are read in the full reading.

Dr. Reddy's Laboratories: common questions

When was Dr. Reddy's Laboratories incorporated?

Dr. Reddy's Laboratories was incorporated on 30 May 2003. Its kundali is cast for that date.

What is Dr. Reddy's Laboratories's lagna and Moon sign?

Dr. Reddy's Laboratories's chart rises in Karka, with its lord Chandra in the 11th house. The Moon is in Vrishabha, Krittika pada 3.

Which dasha is Dr. Reddy's Laboratories running now?

Dr. Reddy's Laboratories is in the Rahu mahadasha and the Guru antardasha, which runs until 19 May 2028. The sub-period inside it, Budh, ends on 9 January 2027.

When did Dr. Reddy's Laboratories list on the NSE?

Dr. Reddy's Laboratories listed on the National Stock Exchange on 30 May 2003.

Which graha rules Dr. Reddy's Laboratories's sector?

Dr. Reddy's Laboratories is in Healthcare. In the classical scheme the sector is ruled by Ketu for research-led pharma, with Rahu for chemicals. Its strength in transit sets the sector's weather; Dr. Reddy's Laboratories's own chart shows how the company is built for it.

Does GrahaEdge give buy or sell calls on Dr. Reddy's Laboratories?

No. GrahaEdge reads the company's chart and history. It gives no share-price targets and no buy, sell or hold calls.